SCNI
Scinai Immunotherapeutics Ltd
NASDAQ: SCNI · HEALTHCARE · BIOTECHNOLOGY
$0.74
+3.67% today
Updated 2026-04-30
Market cap
$2.06M
P/E ratio
0.00
P/S ratio
1.58x
EPS (TTM)
$0.00
Dividend yield
—
52W range
$0 – $3
Volume
4.1M
Scinai Immunotherapeutics Ltd (SCNI) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.50M | $1.37M | — | — | — | — | — | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $658000.00 | $1.31M |
| Revenue growth (YoY) | — | -45.3% | -100.0% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +99.2% |
| Cost of revenue | $1.41M | $969000.00 | $73415.00 | $66962.00 | $76222.00 | $167976.00 | — | — | — | — | — | $123554.00 | $72317.00 | $461688.00 | $708920.00 | $747649.00 | $559801.00 | $512675.00 | $1.24M | $3.96M |
| Gross profit | $1.09M | $398000.00 | $-73415.00 | $-66962.00 | $-76222.00 | $-168000.00 | — | — | — | — | — | — | — | — | $-708920.00 | $-747649.00 | $-559801.00 | $-512675.00 | $-580000.00 | $-2.65M |
| Gross margin | 43.6% | 29.1% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -88.1% | -202.3% |
| R&D | $38000.00 | $35000.00 | $882386.00 | $805335.00 | $1.80M | $1.53M | $1.61M | $1.94M | $1.65M | $1.91M | $2.44M | $5.58M | $19.27M | $19.88M | $16.01M | $3.25M | $5.76M | $5.21M | $5.53M | $2.37M |
| SG&A | $2.05M | $2.54M | — | — | — | — | — | — | — | $3.26M | $4.06M | $4.75M | $5.09M | $9.35M | $5.02M | $7.72M | $5.30M | $4.50M | $2.53M | $2.52M |
| Operating income | — | — | $-1.30M | $-1.17M | $-2.54M | $-2.30M | $-2.38M | $-2.20M | $-2.09M | $-2.90M | $-3.09M | $-6.80M | $-20.61M | $-22.69M | $2.28M | $-10.87M | $-11.06M | $-9.71M | $-8.64M | $-7.54M |
| Operating margin | 0.0% | 0.0% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -1312.8% | -575.3% |
| EBITDA | — | — | $-1.14M | $-1.10M | $-2.41M | $-1.99M | $-2.24M | $-2.00M | $-1.92M | $-2.74M | $-2.93M | $-6.67M | $-20.54M | $-22.21M | $2.75M | $-10.39M | $-10.50M | $-9.19M | $-6.99M | $-6.53M |
| EBITDA margin | 0.0% | 0.0% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -1062.2% | -497.9% |
| EBIT | — | — | $-1.21M | $-1.17M | $-2.49M | $-2.16M | $-2.43M | $-2.20M | $-2.09M | $-2.90M | $-3.09M | $-6.80M | $-20.61M | $-22.67M | $2.28M | $-10.86M | $-11.06M | $-9.71M | $-8.64M | $-7.95M |
| Interest expense | $0.00 | $0.00 | — | — | — | — | — | $1425.00 | $1689.00 | $7.00 | $100.00 | $20452.00 | $3.78M | $4.28M | $348929.00 | $3.36M | $5.05M | $7979.00 | $1.44M | $359000.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | — | — | $-1.21M | $-1.17M | $-2.49M | $-2.16M | $-2.43M | $-2.32M | $-1.99M | $-2.62M | $-2.38M | $-9.93M | $-23.46M | $-31.62M | $-1.39M | $-8.21M | $-5.80M | $-6.50M | $4.80M | $-8.31M |
| Net income growth (YoY) | — | — | — | +3.8% | -113.5% | +13.2% | -12.4% | +4.6% | +14.0% | -31.3% | +8.9% | -316.5% | -136.2% | -34.8% | +95.6% | -492.1% | +29.4% | -12.1% | +173.8% | -273.2% |
| Profit margin | 0.0% | 0.0% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 728.9% | -633.6% |